Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser With or Without Botulinum Toxin for Hypertrophic Burn Scars
NCT07360483Completed
- Sponsor
- Cairo University
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in Hypertrophic Scar (HS) (3 arms), sponsored by Cairo University. Primary endpoints: Patient and Observer Scar Assessment Scale at 3 months and Vancouver Scar Scale at 3 months. Started Jan 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT07360483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07360483.